Air keeps moving through your airways until it reaches tiny balloon-like air sacs in your lungs called alveoli. From there, the oxygen moves into your blood. Healthy lungs carry oxygen from the ...

Updates Guidance on MOLBREEVI BLA Submission Completion Date to End of 1Q 2025 from 1H 2025 – Intends to Request Priority Review Expects to Submit MOLBREEVI Marketing Authorization Application (MAA) ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third quarter ending September 30, 2024 ...

About aPAP Autoimmune PAP (aPAP) is a rare lung disease characterized by the abnormal build-up of surfactant in the alveoli (or air sacs) of the lungs. Surfactant consists of proteins and lipids ...

Updates Guidance on MOLBREEVI BLA Submission Completion Date to End of 1Q 2025 from 1H 2025 – Intends to Request Priority Review Expects to Submit MOLBREEVI Marketing Authorization Application ...

Objective: Recently, natural exogenous surfactant replacement has been used in experimental models and clinical trials for the treatment of severe respiratory syncytial virus (RSV) disease.

THE use of detergents in the liquefaction of thick mucoid and purulent exudates in the alveoli and bronchial tree was not practical until recent years, owing to the fact that no surfactant with ...

In RDS the body fails to produce sufficient natural surfactant to prevent surface tension from collapsing the alveoli of the lungs and so inhibiting normal breathing. It was John Clements, Emeritus ...

(1−3) An additional class of amphiphilic peptide has been termed surfactant-like peptide (SLP). (4−9) Such molecules comprise blocky sequences of hydrophobic and hydrophilic residues, typically a ...

About aPAP Autoimmune PAP (aPAP) is a rare lung disease characterized by the abnormal build-up of surfactant in the alveoli (or air sacs) of the lungs. Surfactant consists of proteins and lipids ...